RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 73 filers reported holding RENEO PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $0 | -100.0% | 46 | -99.4% | 0.00% | – |
| Q1 2024 | $13 | -65.8% | 8,158 | -66.6% | 0.00% | – |
| Q4 2023 | $38 | -93.6% | 24,435 | -68.7% | 0.00% | – |
| Q3 2023 | $595 | +22.9% | 78,118 | +5.7% | 0.00% | – |
| Q2 2023 | $484 | +12.6% | 73,874 | +2.7% | 0.00% | – |
| Q1 2023 | $430 | +156.0% | 71,930 | 0.0% | 0.00% | – |
| Q4 2022 | $168 | -99.9% | 71,930 | 0.0% | 0.00% | – |
| Q3 2022 | $241,000 | +68.5% | 71,930 | +33.3% | 0.00% | – |
| Q2 2022 | $143,000 | +1330.0% | 53,946 | +1414.5% | 0.00% | – |
| Q1 2022 | $10,000 | – | 3,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,534,220 | $4,054,752 | 14.95% |
| BML Capital Management, LLC | 1,314,229 | $2,102,766 | 1.59% |
| Octagon Capital Advisors LP | 2,250,000 | $3,600,000 | 0.58% |
| NEA Management Company, LLC | 4,785,494 | $7,656,790 | 0.51% |
| TANG CAPITAL MANAGEMENT LLC | 3,330,000 | $5,328,000 | 0.49% |
| Aisling Capital Management LP | 886,075 | $1,417,720 | 0.42% |
| Carlyle Group Inc. | 2,698,957 | $4,318,331 | 0.21% |
| Ikarian Capital, LLC | 1,082,600 | $1,732,160 | 0.16% |
| FIFTH LANE CAPITAL, LP | 40,000 | $64,000 | 0.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,121,704 | $1,794,726 | 0.07% |